Department Research
MEDICATION THERAPY SAFETY - DELIRIUM

The work of the delirium research group is focused on elucidating the medication associated risk in the development, treatment and prevention of delirium across all patient groups (paediatric, adults of all ages, peri-operative, dementia and cancer). While the overaching aim is to develop detailed consensus guidelines for clincial practice, we are also interested in contributing pharmacological and physiological mechanisms of medication related risks in this patient group. Small research groups in the department have also done early work in applied artificial intelligence, particularly in addressing medication issues through user-accessible AI pipelines.
Project Partners

University of Iceland

Landspitali Iceland

Queen’s Medical University Belfast

ERASMUS+

Tirol Kliniken
PHARMACIST ROLE PROFILE DEVELOPMENT
Developing the pharmacists role profile across all sectors is another key focus of our research. This includes service development, implementation, behaviour change interventions and evaluation research as well as the development of education and practice competency frameworks. We have paralleled this work with numerous conference presentations, keynote addresses, and PhD supervision, thereby preparing the future practitioners.
Project Partners

University of Copenhagen

LMU

University of Qatar

Klinik Hitzing

Kontonspital Aarau
